European
-
Merck receives European approval to expand use of Rebif
Merck announced that the European Commission (EC) has approved extension of the indication of Rebif (interferon beta-1a), its treatment for relapsing forms of multiple sclerosis (MS).
European | 02 March 2012
-
European Commission approves SUTENT
The European Commission has approved Pfizer 's SUTENT (sunitinib malate) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors (NET) with disease progression in adults. Experience with SUTENT as ini…
European | 23 February 2011
-
Avandia hit hard by European and US regulators
Expert comment from Datamonitor healthcare analyst Christine Henry: "Although Avandia franchise sales have already declined significantly from a high of US$3.2 billion in 2006 worldwide to US$1.2 billion in 2009, the suspension of sales in Europe …
European | 15 October 2010
-
Novartis Granted Pediatric Indication for Hypertension Treatment
The European Commission (EC) has granted Diovan (valsartan) a pediatric indication for the treatment of hypertension in children and adolescents 6-18 years of age. Following the Commission's decision, the pediatric indication needs to be implemented …
European | 13 May 2010
-
AstraZeneca: Diabetes Drug Receives Marketing Authorization In Europe
AstraZeneca and Bristol-Myers Squibb Company have announced that the European Commission has granted marketing authorisation for Onglyza (saxagliptin) in the 27 countries of the European Union. The drug is indicated as a once-daily 5 mg oral tabl…
European | 08 October 2009
-
AstraZeneca Receives Marketing Authorization for Lung Cancer Drug
AstraZeneca has announced that the European Commission has granted marketing authorization for an oral anti-cancer drug. Iressa is used for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activatin…
European | 01 August 2009
-
Philips Leads European Sonodrugs Project
Philips Electronics says it is leading a European project to develop drug delivery technologies that could significantly impact the treatment of cancer and cardiovascular disease. By allowing drugs to be delivered to disease sites via the patient…
European | 09 February 2009
-
Pharmacy Liberalisation on Hold
Yves Bot, Advocate General at the European Court of Justice, has released a non-binding statement supporting German and Italian laws, restricting retailers from owning pharmacies in both countries. According to Bot, the laws are valid if the obje…
European | 26 December 2008
-
AstraZeneca announces European Seroquel XR submission for the treatment of GAD
AstraZeneca has its submission of Seroquel XR (quetiapine fumarate extended release tablets) to European regulatory authorities seeking approval for both short-term and maintenance treatment of Generalised Anxiety Disorder (GAD). This is the firs…
European | 21 October 2008
-
Cymbalta receives European approval to treat GAD
Eli Lilly and Co and Boehringer Ingelheim say the European Commission has approved the use of Cymbalta (duloxetine) for the treatment of generalised anxiety disorder (GAD). This approval – the fourth for duloxetine in Europe - was issued on 28 …
European | 25 August 2008
